Status:
UNKNOWN
Quality of Life of Frail Aged Patients in Incremental Hemodialysis
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Renal Dialysis
Kidney Failure, Chronic
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
End stage renal disease (ESRD) is a major public health problem. The dialysis population is aging. As a result we observe a high prevalence of frailty among dialysis patients (ranges from 3 to 10 fold...
Eligibility Criteria
Inclusion
- For all patients (incident HD patients):
- Patient aged over 60 years
- Signature of informed consent
- Affiliation to a French social security or receiving such a scheme
- Patient with Chronic Kidney Disease Stage 5 (GFR \<15 ml/min/1.73m2)
- Urine output \> 0,5 L per day
- Kru ≥ 2 ml/min
- Outpatient with scheduled start of HD
- Understand and read french
- For randomized patients (frail incident HD patients):
- \- Frailty according to L. Fried criteria: score greater than or equal to 3/5
Exclusion
- Inability to understand the reasons for the study; psychiatric disorders
- Active and/or treated neoplastic disease
- Scheduled kidney transplantation within 6 months
- Solid organ transplanted patient receiving immunosuppressive therapy
- Estimated life expectancy \< 6 months
- Patient with diagnosis of severe chronic heart failure (\> 2 congestive heart failure episodes requiring hospitalization in the year preceding the start of HD)
- Legal disability or limited legal capacity
- Patient without health insurance
- Pregnant
- Patient in the period of exclusion of another study
- Uncooperative patient
Key Trial Info
Start Date :
May 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
783 Patients enrolled
Trial Details
Trial ID
NCT03782519
Start Date
May 9 2019
End Date
December 1 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Besançon
Besançon, France, 25000